Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

May 17, 2010

Primary Completion Date

October 19, 2011

Study Completion Date

November 23, 2015

Conditions
Carcinoma, Renal Cell
Interventions
DRUG

pazopanib

oral anti-angiogenic treatment

DRUG

sunitinib

oral anti-angiogenic treatment

Trial Locations (51)

10117

Novartis Investigative Site, Berlin

13273

Novartis Investigative Site, Marseille

14076

Novartis Investigative Site, Caen

15850

Novartis Investigative Site, Lahti

20052

Novartis Investigative Site, Monza

20520

Novartis Investigative Site, Turku

24128

Novartis Investigative Site, Bergamo

27100

Novartis Investigative Site, Pavia

33075

Novartis Investigative Site, Bordeaux

33081

Novartis Investigative Site, Aviano (PN)

35042

Novartis Investigative Site, Rennes

38642

Novartis Investigative Site, Goslar

41462

Novartis Investigative Site, Neuss

42271

Novartis Investigative Site, Saint-Priest-en-Jarez

47014

Novartis Investigative Site, Meldola (FC)

49933

Novartis Investigative Site, Angers

52074

Novartis Investigative Site, Aachen

53127

Novartis Investigative Site, Bonn

55043

Novartis Investigative Site, Lido Di Camaiore (LU)

55131

Novartis Investigative Site, Mainz

56126

Novartis Investigative Site, Pisa

59020

Novartis Investigative Site, Lille

60220

Novartis Investigative Site, Seinäjoki

65130

Novartis Investigative Site, Vaasa

66100

Novartis Investigative Site, Chieti

67085

Novartis Investigative Site, Strasbourg

67091

Novartis Investigative Site, Strasbourg

68024

Novartis Investigative Site, Colmar

69373

Novartis Investigative Site, Lyon

73100

Novartis Investigative Site, Lecce

75908

Novartis Investigative Site, Paris

76031

Novartis Investigative Site, Rouen

80210

Novartis Investigative Site, Joensuu

81675

Novartis Investigative Site, Munich

83400

Novartis Investigative Site, Hyères

88212

Novartis Investigative Site, Ravensburg

90766

Novartis Investigative Site, Fürth

94805

Novartis Investigative Site, Villejuif

00029

Novartis Investigative Site, Helsinki

00152

Novartis Investigative Site, Rome

Unknown

Novartis Investigative Site, Taormina

B9 5SS

Novartis Investigative Site, Birmingham

BH7 7DW

Novartis Investigative Site, Bournemouth

HU16 5JQ

Novartis Investigative Site, Cottingham

M20 4BX

Novartis Investigative Site, Manchester

NE7 7DN

Novartis Investigative Site, Newcastle upon Tyne

NR4 7UY

Novartis Investigative Site, Norwich

PL6 8DH

Novartis Investigative Site, Plymouth

PR2 9HT

Novartis Investigative Site, Preston

SY3 8XQ

Novartis Investigative Site, Shrewsbury

WV10 0QP

Novartis Investigative Site, Wolverhampton

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY